DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Remicade (Infliximab) - News

 
 



News related to Remicade (Infliximab) and/or conditions it is approved for

Remicade Phase 3 data show long-term psoriasis response
Source: The Doctors Lounge - Dermatology
Findings from two Phase 3 studies show high-level, sustained response with maintenance therapy.

Rheumatic diseases: new results from first real-world study show comparable effectiveness and safety of Inflectra (infliximab)
Source: Arthritis / Rheumatology News From Medical News Today [2015.06.10]
Hospira, Inc., a global leader in biosimilars, has announced the results of an independent clinical study, showing patients with rheumatic diseases experienced comparable clinical effectiveness and...

Time for a switch for patients with 
rheumatoid arthritis and ankylosing spondylitis: Expanding clinical experience with biosimilar infliximab CT-P13
Source: Arthritis / Rheumatology News From Medical News Today [2015.06.10]
The comparable safety and efficacy of switching patients to a biosimilar anti-TNF-α monoclonal antibody from the reference medicinal product (RMP) has been further established in data presented at...

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2015